
==== Front
BMJ Open
BMJ Open
bmjopen
bmjopen
BMJ Open
2044-6055
BMJ Publishing Group BMA House, Tavistock Square, London, WC1H 9JR

39117413
10.1136/bmjopen-2024-085080
bmjopen-2024-085080
Original Research
Nutrition and Metabolism
1714
1506
Is there an association between serum 25-hydroxyvitamin D concentrations and obstructive sleep apnoea? A cross-sectional analysis of NHANES 2007–2008 data
Li Qingyuan 123ft9410253@qq.com

Yao Jun 4liqingyun688@hotmail.com

Duan Ran 15*1345295687@qq.com

http://orcid.org/0000-0002-5413-486X
Feng Tong 6543051181@qq.com

1 Clinical Medical College, Chengdu Medical College, Chengdu, People's Republic of China
2 Department of Respiratory and Critical Care Medicine,The First Affiliated Hospital of Chengdu Medical College, Chengdu, People's Republic of China
3 Laboratory of Geriatic Respiratory Diseases of Sichuan Higher Education Institute, Chengdu, People's Republic of China
4 Department of Respiratory and Critical Care Medicine,Guangyuan Central Hospital, Guangyuan, People's Republic of China
5 Department of Oncology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, People's Republic of China
6 Southern Medical University, Guangzhou, China
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

None declared.

DrTongFeng; 543051181@qq.com
DrRanDuan; 1345295687@qq.com
Deceased: 11

2024
7 8 2024
14 8 e08508005 2 2024
03 7 2024
Copyright © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
2024
https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Abstract

Objectives

The study aimed to investigate the relationship between serum 25-hydroxyvitamin D (25(OH)D) concentrations and obstructive sleep apnoea (OSA) and to assess the confounding effect of body mass index (BMI) on this relationship.

Design

This was a cross-sectional analysis using data from the 2007–08 National Health and Nutrition Examination Survey (NHANES).

Setting

Data were sourced from NHANES, a continuous survey sponsored by the Centres for Disease Control and Prevention, covering residents from 15 urban areas in the United States of America(USA).

Participants

The study included 4901 participants aged 16 years and older who had completed 25(OH)D data and responses to the OSA questionnaire.

Main exposure measure

Serum 25(OH)D concentrations were measured using liquid chromatography-tandem mass spectrometry.

Main outcome measure

The primary outcome was the self-reported diagnosis of OSA from questionnaires.

Results

After adjusting for age, sex and race (model 1), a significant negative association was observed between 25(OH)D and OSA (β=−3.21, 95% CI: −6.17 to –0.26). However, this association was no longer significant after further adjustment for BMI (model 2) (β=1.47, 95% CI: −1.48, 4.42). In the fully adjusted model (model 3), there was no significant association between 25(OH)D and OSA (β=0.92, 95% CI: −1.93, 3.76). Subgroup analyses stratified by sex, age, race or BMI also revealed no significant associations between 25(OH)D and OSA.

Conclusions

The study found no significant association between 25(OH)D and OSA. The observed correlation between lower levels of 25(OH)D and OSA may be due to confounding factors, such as higher BMI in the OSA group. Therefore, improving obesity management in OSA patients may be necessary to prevent 25(OH)D insufficiency. This underscores the importance of comprehensive management of both OSA and obesity to promote optimal health outcomes.

Sleep Medicine
Body Mass Index
Cross-Sectional Studies
Research Fund of Chengdu Medical College grant no: CYFY2017GLPXH08 CYFY2018GLPXH01 Key Laboratory of Geriatrics Respiratory Disease Education Department of Sichuan grant no. (2015) 603
==== Body
pmcSTRENGTHS AND LIMITATIONS OF THIS STUDY

Large and diverse sample size.

Comprehensive adjustment for multiple potential confounders.

Cross-sectional design limits causal inference.

Reliance on self-reported obstructive sleep apnoea diagnosis.

Single measurement of 25-hydroxyvitamin D may not capture seasonal variations.

Introduction

Obstructive sleep apnoea (OSA) is a prevalent sleep-breathing disorder, diagnosed by an Apnoea-Hypopnea Index (AHI) of ≥5/hour.1 It is estimated that up to 40% of individuals classified as obese suffer from OSA, with obesity being a major risk factor for the disorder.2 Furthermore, the prevalence of OSA is high among those who have undergone bariatric surgery, with studies reporting rates as high as 80.5%.3 OSA is not only prevalent but also poses significant health risks that extend beyond sleep disturbances. OSA is associated with numerous adverse health outcomes, including cardiovascular diseases, metabolic disorders and neurocognitive impairments.4 The intermittent hypoxia and sleep fragmentation characteristic of OSA contribute to systemic inflammation, oxidative stress and sympathetic nervous system activation, which in turn, exacerbate these comorbid conditions. Given its widespread prevalence and profound impact on health, it is crucial to explore modifiable risk factors, such as vitamin D deficiency, that may offer potential avenues for intervention and improved management of OSA.

In addition to its role in bone homeostasis,5 25-hydroxyvitamin D (25(OH)D) may also play a role in regulating sleep. This is because vitamin D receptors are present in brain regions that are involved in sleep regulation, such as the hypothalamus, prefrontal cortex, substantia nigra and nucleus accumbens.6 Furthermore, there is evidence to suggest that 25(OH)D deficiency is associated with metabolic disorders similar to OSA, including impaired glucose metabolism, obesity and bone deformities.7

Despite several epidemiological studies suggesting a link between low vitamin D concentrations and OSA, a definitive relationship between 25(OH)D and OSA has yet to be established, and conflicting evidence exists in the literature. For example, a cross-sectional study of 106 Dublin adults classified as either non-OSA or OSA found that lower levels of 25(OH)D were present in the Caucasian OSA population.8 However, a separate study of 121 male OSA patients failed to establish an association between serum 25(OH)D levels and OSA.9 Unfortunately, these studies are subject to various limitations, such as small sample sizes and inadequate control of covariates such as dietary vitamin D intake, physical activity, seasonality and comorbidities. Additionally, it is unclear whether race/ethnicity and obesity status might have an impact on the relationship between 25(OH)D and OSA.

To address these gaps in current knowledge, the aim of this study is to investigate the potential relationship between 25(OH)D and OSA in a population of individuals aged 16 years and older, using a diverse sample with varying ages and ethnicities.

Methods

Study population

This study drew on data obtained from the National Health and Nutrition Examination Survey (NHANES) database, which is sponsored by the Centres for Disease Control and Prevention and operates on a 2-year survey cycle. Beginning in 1999, NHANES has been conducted without interruption. Each year, around 5000 individuals are interviewed in their homes, and physical examinations and biological sample collection are conducted in mobile units. The NHANES survey targets residents from 15 urban areas across the USA, including individuals of African, Asian and Hispanic descent.10

For our study, we analysed NHANES data collected during the 2007–08 survey cycle due to the availability of questionnaire data on sleep apnoea. To ensure data completeness, we excluded participants with missing 25(OH)D data (n=3199) and those with missing responses to the ‘OSA’ question (n=2049). Ultimately, our study sample included 4901 participants (online supplemental figure S1).

The NHANES procedure was authorised by the Institutional Review Board of the National Centre for Health Statistics. Informed consent was obtained from all NHANES participants or their legal representatives (<18 years).11

Obstructive sleep apnea

As a component of the NHANES study, sleep apnoea diagnosis was based on medical condition questionnaires collected through interviews. Participants were asked whether a doctor had ever diagnosed them with a sleep disorder. If so, they were asked to specify the type of sleep disorder from among categories such as OSA, insomnia, restless legs syndrome or other (online supplemental materials).

Serum 25(OH)D

The common gauge of vitamin D nutritional status is the 25(OH)D indicator. Blood samples were obtained from each participant at a mobile examination centre and immediately frozen at 30°C to measure serum 25(OH)D concentrations. For the 2007–08 cycles, chromatography-tandem mass spectrometry was used to determine serum 25(OH)D.

Covariates

Study subjects received questionnaires under the guidance of a professional investigator. The following data associations with 25(OH)D and/or OSA were collected by interview questionnaires: age, sex, race, education level, income to poverty ratio, body mass index (BMI),12 smoking status,13 alcohol use,14 diabetes15 and cardiovascular disease.16

Statistical analysis

The β and accompanying 95% CI for the connection between 25(OH)D and OSA were calculated using a multivariable logistic regression model. In accordance with STROBE’s (Strengthening the Reporting of Observational Studies in Epidemiology) criteria,17 we created three models. The first was a basic model that simply included adjustments for age, sex and race (model 1). BMI was further adjusted in model 2 before being entirely adjusted in model 3, which also took into account all other covariables. To investigate potential modifying variables, subgroup analyses with stratification by age, sex, BMI and race were conducted. A p value of 0.05 was used to determine statistical significance for all analyses, which were performed using the Empower Stats programme and R V.3.4.3.

Results

Study sample

Table 1 provides a breakdown of the study sample, comparing those with and without OSA. The OSA group had a mean age of 53.85±13.87 years, which was older than the non-OSA group (44.81±17.97 years). Additionally, the percentage of men in the OSA group (64.53%) was higher than that of women (47.69%). Significant differences (p<0.05) were found between the two groups in terms of 25(OH)D levels, race, education level, income to poverty ratio, BMI, smoking status, alcohol use, diabetes status and cardiovascular disease.

Table 1 Characteristic of study sample with and without OSA

Characteristic	Non-OSA (n=4671)	OSA (n=230)	P value	
Age (years)	44.81±17.97	53.85±13.87	<0.001	
Gender (%)			<0.001	
Female	2443 (52.31%)	82 (35.47%)		
Male	2228 (47.69%)	148 (64.53%)		
Race (%)			0.01	
Non-Hispanic White	3287 (70.36%)	181 (78.94%)		
Non-Hispanic Black	479 (10.26%)	23 (9.93%)		
Mexican American	413 (8.84%)	9 (4.13%)		
Other race	492 (10.54%)	16 (7.00%)		
Body mass index (kg/m²)	28.02±6.36	33.99±8.35	<0.001	
Education (%)			0.06	
Less than high school	311 (6.67%)	9 (3.97%)		
High school	1948 (41.72%)	83 (36.32%)		
More than high school	2406 (51.55%)	138 (59.71%)		
Not recorded	6 (0.06%)	0 (0%)		
Income to poverty ratio	2.97±1.61	3.41±1.62	<0.001	
Smoking behaviour (%)			<0.001	
None	2319 (49.66%)	114 (49.55%)		
Past	1051 (22.51%)	80 (34.59%)		
Current	951 (20.36%)	35 (15.33%)		
Not recorded	350 (7.47%)	1 (0.53%)		
Alcohol consumption (%)			<0.001	
None	486 (10.41%)	25 (10.75%)		
Past	674 (14.42%)	60 (26.19%)		
Mild	1412 (30.23%)	78 (33.84%)		
Moderate	623 (13.34%)	28 (12.26%)		
Heavy	874 (18.73%)	22 (9.48%)		
Not recorded	602 (12.87%)	17 (7.49%)		
Physical activity (%)			0.02	
Mild	570 (12.20%)	33 (14.51%)		
Moderate	1353 (28.98%)	62 (26.90%)		
Heavy	1732 (37.09%)	76 (33.09%)		
Not recorded	1016 (21.73%)	59 (25.51%)		
Diabetes (%)			<0.001	
No	4257 (91.15%)	177 (77.14%)		
Yes	378 (8.09%)	53 (22.86%)		
Not recorded	36 (0.76%)	0 (0%)		
Cardiovascular disease (%)			<0.001	
No	3431 (73.47%)	171 (74.35%)		
Yes	1190 (25.48%)	57 (24.78%)		
Not recorded	50 (1.07%)	2 (0.87%)		
Serum vitamin D (ng/mL)	67.46±26.15	65.03±26.80	0.1596	
Dietary vitamin D intake (mcg)	0.66±0.47	0.51±0.50	<0.001	
Vitamin D supplement use (%)		<0.001	
No	3249 (69.55%)	137 (59.57%)		
Yes	1422 (30.45%)	93 (40.43%)		
Months of blood collection (%)		0.6912	
1 May through 31 October	2985 (63.89%)	151 (65.65%)		
1 November through 30 April	1686 (36.11%)	79 (34.35%)		
Mean±SD for continuous variables,. Per cent for categorical variables.OSA,.

OSAobstructive sleep apnoea

Multiple regression model

Table 2 displays the results of the regression analyses investigating the association between 25(OH)D and OSA. After adjusting for age, sex and race (model 1), a significant negative association was observed (β=−3.21, 95% CI −6.17 to –0.26). However, when BMI was adjusted as an additional covariate (model 2), this relationship was no longer significant (β=1.47, 95% CI −1.48, 4.42). In the fully adjusted model (model 3), which adjusting all potential confounding variables, there was no significant association between OSA and 25(OH)D (β=0.92, 95% CI −1.93, 3.76).

Table 2 Associations between OSA and serum vitamin D

	Model 1	Model 2	Model 3	
Non-OSA	Reference	Reference	Reference	
OSAβ (95% CI)	−3.21 (−6.17, –0.26)	1.47 (−1.48, 4.42)	0.92 (−1.93, 3.76)	
P value	0.03	0.3297	0.5268	
Model 1: age, sex, and race were adjusted.

Model 2:. age, sex, race, and body mass index were adjusted.

Model 3: age, sex, race, education level, income to poverty ratio, body mass index, smoking status, alcohol use, diabetes, and cardiovascular disease were adjusted.OSA,.

OSAobstructive sleep apnoea

Subgroup analyses

When stratified by sex, age and race (tables35), no significant associations between OSA and 25(OH)D were found in the 16–19 years group (β=7.99, 95% CI −21.42, 37.40), 20–59 years group (β=2.34, 95% CI −1.53, 6.20) or 60–85 years group (β=−0.25, 95% CI −4.47, 3.96). Similarly, there were no significant associations observed in either males (β=−0.65, 95% CI −1.51, 0.21) or females (β=0.65, 95% CI −0.76, 2.07) nor in non-Hispanic White (β=1.96, 95% CI −2.10, 6.03), non-Hispanic Black (β=1.52, 95% CI −4.11, 7.16), Mexican American (β=−6.39, 95% CI −13.85, 1.06) or other race (β=3.58, 95% CI −4.69, 11.85) groups. Additionally, there was no significant association observed in participants with BMI <25 (kg/m²) (β=4.48, 95% CI −4.69, 11.85), those with BMI inside 25–29.9 (kg/m²) (β=−0.03, 95% CI −5.49, 5.43) or those with BMI ≥30 (kg/m²) (β=−1.37, 95% CI −4.50, 1.76) (online supplemental table S1). Furthermore, the impact of OSA on 25(OH)D was not found to be affected by sex, age, race or BMI (p for all interactions >0.05).

Table 3 Associations between OSA and serum vitamin D stratified by age

	Model 1	Model 2	Model 3	P for interaction	
16–19 years				0.9806	
β (95% CI)	3.87 (−26.61, 34.35)	14.62 (−15.38, 44.62)	7.99 (−21.42, 37.40)		
P value	0.8034	0.3400	0.5948		
20–59 years					
β (95% CI)	−3.63 (−7.57, 0.31)	2.04 (−1.89, 5.97)	2.34 (−1.53, 6.20)		
P value	0.0713	0.3088	0.2366		
59–85 years					
β (95% CI)	−2.37 (−6.87, 2.12)	0.83 (−3.71, 5.37)	−0.25 (−4.47, 3.96)		
P value	0.3011	0.7189	0.9069		
Model 1: sex, and race were adjusted.

Model 2:. sex, race, and body mass index were adjusted.

Model 3: sex, race, education level, income to poverty ratio, body mass index, smoking status, alcohol use, diabetes, and cardiovascular disease were adjusted.

OSAobstructive sleep apnoea

Table 4 Associations between OSA and serum vitamin D stratified by sex

	Model 1	Model 2	Model 3	P for interaction	
Sex				0.6048	
Male					
β (95% CI)	−3.37 (−6.58, –0.15)	0.02 (−3.26, 3.30)	−0.65 (−1.51, 0.21)		
P value	0.0404	0.9908	0.1402		
Female					
β (95% CI)	−2.81 (−8.33, 2.71)	2.86 (−2.57, 8.29)	2.97 (−2.24, 8.17)		
P value	0.3178	0.3025	0.2639		
Model 1: age, and race were adjusted.

Model 2:. age, race, and body mass index were adjusted.

Model 3: age, race, education level, income to poverty ratio, body mass index, smoking status, alcohol use, diabetes, and cardiovascular disease were adjusted.

OSAobstructive sleep apnoea

Table 5 Associations between OSA and serum vitamin D stratified by race

	Model 1	Model 2	Model 3	P for interaction	
Race				0.4716	
Non-Hispanic White					
β (95% CI)	−2.49 (−6.77, 1.79)	3.55 (−0.66, 7.77)	1.96 (−2.10, 6.03)		
P value	0.2544	0.0986	0.3435		
Non-Hispanic Black					
β (95% CI)	−1.79 (−7.53, 3.94)	1.66 (−4.16, 7.48)	1.52 (−4.11, 7.16)		
P value	0.5401	0.5761	0.5958		
Mexican American					
β (95% CI)	12.31 (−19.91, –4.72)	−9.49 (−17.06, –1.92)	−6.39 (−13.85, 1.06)		
P value	0.0015	0.0143	0.0932		
Other race					
β (95% CI)	−0.67 (−9.23, 7.89)	3.65 (−5.03, 12.32)	3.58 (−4.69, 11.85)		
P value	0.8778	0.4104	0.3966		
Model 1: age, and sex were adjusted.

Model 2:. age, sex, and body mass index were adjusted.

Model 3: age, sex, education level, income to poverty ratio, body mass index, smoking status, alcohol use, diabetes, and cardiovascular disease were adjusted.

OSAobstructive sleep apnoea

Discussion

After adjusting for BMI and other covariates (sex, education level, income to poverty ratio, smoking status, alcohol use, diabetes and cardiovascular disease), the statistically significant association between 25(OH)D and OSA was no longer observed. This non-significance was further confirmed in all subanalyses stratified by age, gender, race and BMI.

Our study results contradict earlier research conducted by Mete et al who observed a lower vitamin D level in OSA patients with an AHI ≥30/hour compared with those with an AHI ≤5/hour.18 However, it should be noted that Mete et al’s study focused solely on obese patients, thus, failing to consider the impact of BMI on the association between 25(OH)D and AHI. In contrast, two recent studies, which controlled for BMI, found no evidence linking 25(OH)D to OSA.9 19 These findings are consistent with our study. After controlling for potential confounding variables such as BMI, the authors of a study that included 121 adults performed multinomial regression analysis and found no significant association between the severity of OSA and vitamin D levels. The results of the correlation analysis also revealed a non-significant relationship between vitamin D levels and Apnoea–Hypopnoea Index (r=0.017, p=0.877). In light of these findings, it can be inferred that vitamin D status does not impact the severity of OSA.9 Similarly, a Mendelian randomisation study determined that there was no significant association between 25(OH)D and OSA after controlling for BMI and other relevant confounding variables.19 These findings suggest that the reduction in 25(OH)D levels in OSA patients may be due to a common confounding factor, BMI. Considering the differences in 25(OH)D levels among various races,20 subgroup analyses were performed. In the stratified analysis of race, 25(OH)D was not found to be associated with OSA among non-Hispanic White, non-Hispanic Black, Mexican American or other races. Similarly, consistent outcomes were evident in the subgroup analyses conducted based on age, gender and BMI.

Obesity represents one of the prevalent risk factors shared by both 25(OH)D deficiency and OSA. Our findings further reveal that BMI significantly impacts the association between 25(OH)D and OSA. Therefore, when investigating the link between 25(OH)D and OSA, BMI needs to be considered, with the following explanations serving as partial justification. One plausible explanation is that obese individuals possess greater adipose tissue mass, leading to increased 25(OH)D uptake and storage.21 Additionally, a volume dilution effect may come into play, whereby 25(OH)D is dispersed across a larger area of adipose tissue, liver and muscle.22 At the same time, obese individuals may frequently inhabit indoor settings, limiting their exposure to sunlight and potentially resulting in decreased synthesis of 25(OH)D.23

To the best of our knowledge, this study represents the most comprehensive investigation of the correlation between OSA and 25(OH)D levels in a multiethnic sample, which can serve as a surrogate for assessing the entire population. Moreover, the extensive data collected in the NHANES allowed us to consider an array of potential confounders, including dietary vitamin D intake, physical activity, seasonality and comorbidities. There are also some limitations worth noting. First, the diagnosis of OSA relied on self-reported symptoms of sleep apnoea, without objective measurements, which may have led to misclassification of OSA. Misclassification due to undiagnosed mild to moderate OSA may lead to underestimation of the association if mild to moderate OSA increases the risk of vitamin D deficiency. However, the study used a large sample from NHANES surveys, resulting in broad coverage and representativeness. Additionally, self-administered questionnaires have been widely used for evaluating self-reported OSA.13 24 The high prevalence of OSA in the sample under study, which closely matches previous population prevalence estimates of sleep apnoea syndrome,25 lends support to the accuracy of health-professional-diagnosed self-report as a diagnostic tool.26 27 Second, a significant factor affecting endogenous vitamin D levels was not accounted for in the research design. Geographical location is an important determinant of sunlight exposure,18 28 but this information was not collected. However, a previous study found no significant association between geographical location and 25(OH)D levels, suggesting that the impact of geographical location on 25(OH)D levels may be negligible.29 It is worth noting that 25(OH)D levels exhibit seasonal variation,30 and a single 25(OH)D measurement may not capture the full spectrum of year-round 25(OH)D fluctuations. Third, it should be noted that the present study’s cross-sectional methodology limits its ability to determine the causal relationship between 25(OH)D and OSA. Fourth, the investigation into the relationship between different degrees of OSA and 25(OH)D was not conducted, as the severity of OSA was not assessed in the present study. Fifth, while 25(OH)D is considered a superior marker for assessing vitamin D status, future research could explore the use of bioavailable vitamin D as an alternative marker.20 31 Overall, these limitations must be taken into account when interpreting the findings of the present study.

Conclusions

Our study did not find a significant association between OSA and 25(OH)D. However, it is possible that the observed association between lower 25(OH)D levels and OSA could be attributed to confounding factors such as higher BMI levels in the OSA group. In order to prevent 25(OH)D insufficiency in individuals with OSA, there is a need to improve the management of obesity. Thus, our study highlights the importance of comprehensive management of both OSA and obesity for promoting optimal health outcomes.

supplementary material

10.1136/bmjopen-2024-085080 online supplemental file 1

Acknowledgements

Thanks to Jing Zhang (Shanghai Tongren Hospital) for his work on the NHANES database.

His outstanding work, nhanesR package and webpage, makes it easier for us to explore the NHANES database.

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information.

Review Process File
7 8 2024

Funding: The present study was supported by the Key Laboratory of Geriatrics Respiratory Disease Education Department of Sichuan [grant no. (2015) 603] and Research Fund of Chengdu Medical College (grant no: CYFY2017GLPXH08 CYFY2018GLPXH01).

Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online (https://doi.org/10.1136/bmjopen-2024-085080 ).

Provenance and peer review: Not commissioned; externally peer reviewed.

Patient consent for publication: Consent obtained directly from patient(s).

Ethics approval: The ethics review board of the National Center for Health Statistics approved all NHANES protocols and written informed consents were obtained from all participants or their proxies (<18 years). The study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Bioethics Committee of Southern Medical University reviewed our study and have waived the need for ethical approval.

Data availability free text: The survey data are publicly available on the internet for data users and researchers throughout the world (www.cdc.gov/nchs/nhanes/).

Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.
==== Refs
References

1 Benjafield AV Ayas NT Eastwood PR et al Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis Lancet Respir Med 2019 7 687 98 10.1016/S2213-2600(19)30198-5 31300334
2 Svatikova A Wolk R Gami AS et al Interactions between obstructive sleep apnea and the metabolic syndrome Curr Diab Rep 2005 5 53 8 10.1007/s11892-005-0068-2 15663918
3 Loo GH Rajan R Mohd Tamil A et al Prevalence of obstructive sleep apnea in an Asian bariatric population: an underdiagnosed dilemma Surg Obes Relat Dis 2020 16 778 83 10.1016/j.soard.2020.02.003 32199766
4 Gaines J Vgontzas AN Fernandez-Mendoza J et al Obstructive sleep apnea and the metabolic syndrome: the road to clinically-meaningful phenotyping, improved prognosis, and personalized treatment Sleep Med Rev 2018 42 211 9 10.1016/j.smrv.2018.08.009 30279095
5 Pan K Tu R Yao X et al Associations between serum calcium, 25(OH)D level and bone mineral density in adolescents Adv Rheumatol 2021 61 16 10.1186/s42358-021-00174-8 33691805
6 Bivona G Gambino CM Iacolino G et al Vitamin D and the nervous system Neurol Res 2019 41 827 35 10.1080/01616412.2019.1622872 31142227
7 Melguizo-Rodríguez L Costela-Ruiz VJ García-Recio E et al Role of vitamin D in the metabolic syndrome Nutrients 2021 13 830 10.3390/nu13030830 33802330
8 Kerley CP Hutchinson K Bolger K et al Serum vitamin D is significantly inversely associated with disease severity in caucasian adults with obstructive sleep apnea syndrome Sleep 2016 39 293 300 10.5665/sleep.5430 26414899
9 Yassa OY Domac SF Kenangil G Serum vitamin D status does not correlate with the severity of obstructive sleep apnea in male adults: a controlled study design with minimized factors influencing serum vitamin D levels Int J Vitam Nutr Res 2020 90 470 6 10.1024/0300-9831/a000539 30782107
10 Dillon CF Weisman MH US National health and nutrition examination survey arthritis initiatives, methodologies and data Rheum Dis Clin North Am 2018 44 215 65 10.1016/j.rdc.2018.01.010 29622293
11 Zipf G Chiappa M Porter KS et al National health and nutrition examination survey: plan and operations, 1999-2010 Vital Health Stat 2013 1 37
12 Young T Skatrud J Peppard PE Risk factors for obstructive sleep apnea in adults JAMA 2004 291 2013 6 10.1001/jama.291.16.2013 15113821
13 Cavallino V Rankin E Popescu A et al Antimony and sleep health outcomes: NHANES 2009-2016 Sleep Health 2022 8 373 9 10.1016/j.sleh.2022.05.005 35753957
14 Chakravorty S Chaudhary NS Brower KJ Alcohol dependence and its relationship with insomnia and other sleep disorders Alcohol Clin Exp Res 2016 40 2271 82 10.1111/acer.13217 27706838
15 Ogilvie RP Patel SR The epidemiology of sleep and diabetes Curr Diab Rep 2018 18 82 10.1007/s11892-018-1055-8 30120578
16 Tobaldini E Costantino G Solbiati M et al Sleep, sleep deprivation, autonomic nervous system and cardiovascular diseases Neurosci Biobehav Rev 2017 74 321 9 10.1016/j.neubiorev.2016.07.004 27397854
17 von Elm E Altman DG Egger M et al The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies Lancet 2007 370 1453 7 10.1016/S0140-6736(07)61602-X 18064739
18 Mete T Yalcin Y Berker D et al Obstructive sleep apnea syndrome and its association with vitamin D deficiency J Endocrinol Invest 2013 36 681 5 10.3275/8923 23558409
19 Luo X Chang R Zhang J et al Bi-directional and multivariate mendelian randomization analysis of the relationship between circulating 25-hydroxyvitamin D concentration and obstructive sleep apnea BMC Pulm Med 2022 22 380 10.1186/s12890-022-02172-y 36241991
20 Powe CE Evans MK Wenger J et al Vitamin D-binding protein and vitamin D status of black Americans and white Americans N Engl J Med 2013 369 1991 2000 10.1056/NEJMoa1306357 24256378
21 Grace C Vincent R Aylwin SJ High prevalence of vitamin D insufficiency in a United Kingdom urban morbidly obese population: implications for testing and treatment Surg Obes Relat Dis 2014 10 355 60 10.1016/j.soard.2013.07.017 24411192
22 Vranić L Mikolašević I Milić S Vitamin D deficiency: consequence or cause of obesity? Medicina (Kaunas) 2019 55 541 10.3390/medicina55090541 31466220
23 de Oliveira DL Hirotsu C Tufik S et al Vitamin D and sleep apnea: beyond a simple association J Clin Sleep Med 2015 11 1345 10.5664/jcsm.5206 26350605
24 Thakre TP Mamtani M Ujaoney S et al Association of plasma homocysteine with self-reported sleep apnea is confounded by age: results from the national health and nutrition examination survey 2005-2006 Sleep Disord 2012 2012 634920 10.1155/2012/634920 23471122
25 Young T Palta M Dempsey J et al The occurrence of sleep-disordered breathing among middle-aged adults N Engl J Med 1993 328 1230 5 10.1056/NEJM199304293281704 8464434
26 Huang T Lin BM Stampfer MJ et al Associations of self-reported obstructive sleep apnea with total and site-specific cancer risk in older women: a prospective study Sleep 2021 44 10.1093/sleep/zsaa198
27 Huang T Lin BM Markt SC et al Sex differences in the associations of obstructive sleep apnoea with epidemiological factors Eur Respir J 2018 51 1702421 10.1183/13993003.02421-2017 29449424
28 Jean G Souberbielle JC Chazot C Vitamin D in chronic kidney disease and dialysis patients Nutrients 2017 9 328 10.3390/nu9040328 28346348
29 Neighbors CLP Noller MW Song SA et al Vitamin D and obstructive sleep apnea: a systematic review and meta-analysis Sleep Med 2018 43 100 8 10.1016/j.sleep.2017.10.016 29482804
30 Kasahara AK Singh RJ Noymer A Vitamin D (25OHD) serum seasonality in the United States PLoS One 2013 8 e65785 10.1371/journal.pone.0065785 23805188
31 Sun Q Pan A Hu FB et al 25-Hydroxyvitamin D levels and the risk of stroke: a prospective study and meta-analysis Stroke 2012 43 1470 7 10.1161/STROKEAHA.111.636910 22442173
